Drug Index

Muromonab CD3

 
print

Mechanism :

Blocks function of CD3 in T lymphocytes.


Indication :

• Acute Allograft Rejection or Acute Graft-Vs-Host Disease Treatment


Contraindications :

Hypersensitivity to any murine-derived products, Anti-mouse Ab titres = 1:1000, Uncontrolled heart failure or fluid overload, uncontrolled hypertension, history of seizures, pregnancy, breastfeeding.


Dosing :

<30 kg: 2.5 mg IV daily x 10-14 days.

>30 kg: 5 mg IV daily x 10-14 days.

May titrate daily by 2.5 mg to achieve CD3+cells <25/cumm and serum muromonab-CD3 >800 ng/mL.


Adverse Effect :

Pyrexia, chills, dyspnea, nausea, chest pain, diarrhea, tremors, wheezing, headache, tachycardia, hypotension, vomiting, anaphylaxis.


Interaction :

Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of live vaccines.


07/15/2019 06:43:07 Muromonab CD3
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0